Publicaciones en colaboración con investigadoras/es de University of Amsterdam (24)

2024

  1. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 5, pp. 994-1004.e10

2023

  1. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

    Arthritis and Rheumatology, Vol. 75, Núm. 12, pp. 2195-2206

  2. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 75, Núm. 5, pp. 998-1006

  3. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 927-936

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

  2. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

    Cancers, Vol. 14, Núm. 10

  3. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 8, pp. 1143-1150

2021

  1. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

    Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1789-1795

  2. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 11, pp. 2791-2800

  3. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

    PLoS ONE, Vol. 16, Núm. 8

2020

  1. Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach

    Arthritis Care and Research, Vol. 72, Núm. 12, pp. 1800-1808

  2. Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)

    European Journal of Health Economics, Vol. 21, Núm. 7, pp. 1059-1073

  3. Personalised surveillance for serrated polyposis syndrome: Results from a prospective 5-year international cohort study

    Gut, Vol. 69, Núm. 1, pp. 112-121

  4. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 106

2019

  1. Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort

    Arthritis Care and Research, Vol. 71, Núm. 7, pp. 893-902

  2. Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study

    American Journal of Gastroenterology, Vol. 114, Núm. 9, pp. 1512-1519

2018

  1. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

2016

  1. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies: Evidence and clinical judgment

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 285-290

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

    Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961